Induction of mitochondria-involved apoptosis in estrogen receptor-negative cells by a novel tamoxifen derivative, ridaifen-B

Cancer Science

Volumn 99, Issue 3, 2008, Pages 608-614

  Nagahara, Yukitoshi ^a   Shiina, Isamu ^b   Nakata, Kenya ^b   Sasaki, Akane ^b   Miyamoto, Tomomi ^b   Ikekita, Masahiko ^b  

^a TOKYO DENKI UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 IODOTAMOXIFEN; 4 BROMOTAMOXIFEN; ANTINEOPLASTIC AGENT; BIS(DIMETHYLAMINOPHENETOLE); CASPASE; CELL DNA; DNA FRAGMENT; ESTROGEN RECEPTOR; IDOXIFENE; PROTEIN BCL 2; RIDAIFEN B; TAMOXIFEN; TAMOXIFEN DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DAMAGE; CELL STRAIN HL 60; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 38949168067     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00709.x     Document Type: Article

References (26)

1. Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor transcription and transactivation. Estrogen receptor α and estrogen receptor β: Regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res 2000; 2: 335-44.
2. Shiau AK, Barstad D, Loria PM et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998; 95: 927-37.
3. Mosselman S, Polman J, Dijkema R. ER β: Identification and characterization of a novel human estrogen receptor. FEBS Lett 1996; 392: 49-53.
4. Imamov O, Shim GJ, Warner M, Gustafsson JA. Estrogen receptor β in health and disease. Biol Reprod 2005; 73: 866-71.
5. Mandlekar S, Kong AN. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 2001; 6: 469-77.
6. Ferlini C, Scambia G, Marone M et al. Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines. Br J Cancer 1999; 79: 257-63.
7. Kang Y, Cortina R, Perry RR. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells. J Natl Cancer Inst 1996; 88: 279-84.
8. Zamzami N, Marzo I, Susin SA et al. The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition. Oncogene 1998; 16: 1055-63.
9. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 1996; 86: 147-57.
10. Narita M, Shimizu S, Ito T et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 1998; 95: 14.681-6.
11. Zha J, Harada H, Osipov K, Jockel J, Waksman G, Korsmeyer SJ. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J Biol Chem 1997; 272: 24.101-4.
12. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-90.
13. Li P, Nijhawan D, Budihardjo I et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-89.
14. Mandlekar S, Yu R, Tan TH, Kong AN. Activation of caspase-3 and c-Jun NH 2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of homan breast cancer cells. Cancer Res. 2000; 60: 5995-6000.
15. Dhingra K. Antiestrogens - tamoxifen, SERMs and beyond. Invest New Drugs 1999; 17: 285-311.
16. Nuttall ME, Bradbeer JN, Stroup GB et al. Idoxifene: A novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats. Endocrinology 1998; 139: 5224-34.
17. Danel L, Menouni M, Cohen JH et al. Distribution of androgen and estrogen receptors among lymphoid and haemopoietic cell lines. Leuk Res 1985; 9: 1373-8.
18. Shiina I, Suzuki M, Yokoyama K. Short-step synthesis of tamoxifen and its derivatives via the three-component coupling reaction and migration of the double bond. Tetrahedron Lett 2004; 45: 965-7.
19. Shiina I, Sano Y, Nakata K et al. Synthesis of the new pseudo-symmetrical tamoxifen derivatives and their anti-tumor activity. Bioorg Med Chem Lett 2007; 17: 2421-4.
20. Shiina I, Sano Y, Nakata K et al. An expeditious synthesis of tamoxifen, a representative SERM (selective estrogen receptor modulator), via the three-component coupling reaction among aromatic aldehyde, cinnamyltrimethylsilane, and β-chlorophenetole. Bioorg Med Chem 2007; 15: 7599-617.
21. Shiina I, Sano Y, Nakata K et al. Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents. Biochem Pharm 2007; Epub 22 Nov 2007: Doi: 10.1016/ j.bcp.2007.11.005.
22. Cai J, Jones DP. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 1998; 273: 11.401-4.
23. Cheng J, Park TS, Chio LC, Fischl AS, Ye XS. Induction of apoptosis by sphingoid long-chain bases in Aspergillus nidulans. Mol Cell Biol 2003; 23: 163-77.
24. Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell 1996; 85: 817-27.
25. Slee EA, Harte MT, Kluck RM et al. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2-3-6-7-8, and -10 in a caspase-9-dependent manner. J Cell Biol 1999; 144: 281-92.
26. Kallio A, Zheng A, Dahllund J, Heiskanen KM, Harkonen P. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells. Apoptosis 2005; 10: 1395-410.